Conference Information

  1. Home
  2. Conference information

Scientific Committee

Dr. Barney Graham
NIH, Deputy Director and Chief, Viral Pathogenesis Laboratory
Dr. Mélanie Saville
Director, Vaccine Development, CEPI
Prof. Dr. Johan Neyts
Rega Institute Louvain, Belgium, specialist of DNA vaccine PLLAV
Dr. Marion Gruber
FDA, Director, Office of Vaccine Research and Review – CBER
Dr. Ivo Claassen
EMA, Head of Veterinary Medicines Division
Dr. Marco Cavaleri
EMA, Head of Anti-infectives and Vaccines
Prof Dr. Jeffery Almond
Oxford University; Chairman of the Board, Osivax
Dr. Jean-Christophe Audonnet
Senior Director, R&D International Governance | Coordinator ZAPI-IMI Project, Boehringer Ingelheim Animal Health | ZAPI coordinator
Dr. Emmanuel Hanon
Senior Vice President, Head of R&D, GSK Vaccines
Dr Ajoy Chakrabarti
BMGF Vaccine Development
Dr Steve Black
The Brighton Collaboration, Task Force for Global Health

Scientific Agenda

The updated Scientific Agenda will be available soon!

Confirmed Speakers

Joris Vandeputte
International Alliance for Biological Standardization (IABS)
See the Biosketch See the Abstract
David Vaughn
Bill & Melinda Gates Foundation
See the Biosketch See the Abstract
Ivo Claassen
Europen Medicines Agency (EMA)
See the Biosketch See the Abstract
Ralf Wagner
Paul-Ehrlich-Institut (PEI)
See the Biosketch See the Abstract
Jayanthi Wolf
Merck
See the Biosketch See the Abstract
Carmen Jungbäck
International Alliance for Biological Standardization (IABS)
See the Biosketch See the Abstract
Jean-Christophe Audonnet
Boehringer-Ingelheim
See the Biosketch See the Abstract
Carol Gibbs
U.S. Department of Agriculture
See the Biosketch See the Abstract
Mark van Ooij
Janssen Vaccines
See the Biosketch See the Abstract
Nicholas Jackson
Coalition for Epidemics Preparedness Innovation (CEPI)
See the Biosketch See the Abstract
Svein Rune Andersen
Coalition for Epidemics Preparedness Innovation (CEPI)
See the Biosketch See the Abstract
Dean Smith
Health Canada
See the Biosketch See the Abstract
Kaat Smits
Federal Agency for Medicines and Health Products (FAMHP)
See the Biosketch See the Abstract
Stephen Luby
Stanford University
See the Biosketch See the Abstract
Pieter Neels
International Alliance for Biological Standardization (IABS)
See the Biosketch See the Abstract
Steve Black
Global Vaccine Data Network
See the Biosketch See the Abstract
Jean-Michel Dongé
University of Namur
See the Biosketch See the Abstract
Jakob Cramer
Coalition for Epidemics Preparedness Innovation (CEPI)
See the Biosketch See the Abstract
Mimi Darko
African Vaccine Regulatory Forum (AVAREF)
See the Biosketch See the Abstract
Deborah Yeskey
Coalition for Epidemics Preparedness Innovation (CEPI)
See the Biosketch See the Abstract
Marco Cavaleri
Europen Medicines Agency (EMA)
See the Biosketch See the Abstract
Marion Gruber
Food & Drug administration (FDA)
See the Biosketch See the Abstract
Carmen Rodriguez-Hermandez
World Health Organization (WHO)
See the Biosketch See the Abstract
Ajoy Chakrabarti
Bill & Melinda Gates Foundation
See the Biosketch See the Abstract
Klaus Cichutek
Paul-Ehrilich-Institut (PEI)
See the Biosketch See the Abstract
Jean Lang
Sanofi Pasteur
See the Biosketch See the Abstract
Mac Lumpkin
Bill & Melinda Gates Foundation
See the Biosketch See the Abstract
Daniel Brasseur
TBC
See the Biosketch See the Abstract

Meeting Slides

The Meeting Slides will be available soon! test

Organizer

The International Alliance for Biological Standardization (IABS) is an independent, non-profit scientific Alliance, governed by Articles 60-79 of the Swiss Civil code and by its Constitution. Its office is located in Geneva (Switzerland). IABS has members in over 50 countries.

Officers

Mission

IABS is devoted to the scientific and medical advancement of biologicals, by facilitating communication among those who develop, produce and regulate biological products for human and animal health.

Publications

Reports and proceedings of IABS conferences and workshops appear in its journal Biologicals, published by Elsevier and /or in the series Developments in Biologicals published by Karger.

Benefits of IABS Membership

As an Individual Member of IABS, you will:

  • Join a community of recognized experts
  • Receive a reduced fee for an electronic subscription to our journal Biologicals
  • Receive a reduced registration fee for IABS conferences and symposia
  • Have an opportunity to share thoughts, ideas and suggestions on IABS meetings, activities and goals via the dedicated member section on our website
  • Have the opportunity to vote in the election of IABS Board members

For more information on how to become a member of IABS, please visit: www.iabs.org